respiratori
infect
import
complic
pediatr
patient
undergo
hematopoiet
stem
cell
transplant
hsct
broadspectrum
antibiot
administ
children
hsct
prevent
bacteri
pneumonia
antifung
agent
strict
screen
system
use
prophylaxi
fatal
fungal
infect
effort
effect
improv
surviv
hsct
patient
howev
respiratori
viral
infect
common
caus
upper
respiratori
infect
uri
clinic
signific
infect
histor
underestim
hsct
popul
respiratori
viral
infect
caus
progress
uri
lower
respiratori
tract
infect
lrti
frequent
associ
bacteri
fungal
coinfect
past
yr
infect
due
respiratori
virus
increasingli
recogn
potenti
caus
sever
pneumonia
hsct
high
morbid
mortal
mani
advanc
made
diagnosi
respiratori
viral
infect
manag
infect
avail
method
viru
detect
includ
antigen
detect
enzymelink
immunosorb
assay
elisa
immunofluoresc
assay
enzymat
detect
chemic
reaction
polymeras
chain
reaction
pcr
amplif
pcr
assay
commonli
use
due
high
specif
sensit
detect
respiratori
viral
infect
improv
due
mani
avail
diagnost
test
therapeut
modal
use
specif
antivir
agent
remain
limit
studi
perform
evalu
preval
respiratori
viral
infect
pediatr
hsct
recipi
character
clinic
manifest
respiratori
viral
infect
children
hsct
studi
recruit
cohort
children
underw
hsct
seoul
nation
univers
children
hospit
januari
march
follow
least
yr
hsct
clinic
virolog
data
extract
prospect
compil
integr
databas
respiratori
specimen
obtain
routin
patient
care
respiratori
sampl
collect
patient
visit
emerg
room
hospit
elig
subject
febril
episod
respiratori
symptom
radiolog
abnorm
total
respiratori
specimen
collect
clinic
episod
occur
children
consecut
hsct
cohort
via
nasopharyng
aspir
transtrach
aspir
sputum
bronchoalveolar
lavag
specimen
test
multiplex
revers
transcript
pcr
rtpcr
respiratori
virus
rhinoviru
adenoviru
respiratori
syncyti
viru
rsv
type
b
parainfluenza
viru
piv
type
influenza
viru
type
b
human
coronaviru
hcov
human
metapneumoviru
hmpv
influenza
viru
exclud
studi
viral
rna
extract
specimen
use
magna
pure
lc
roch
diagnost
seoul
korea
accord
manufactur
instruct
pcr
amplif
perform
use
ace
detect
kit
seegen
seoul
korea
hospit
record
subject
review
use
standard
form
clinic
data
identifi
respiratori
viral
infect
evalu
clinic
factor
uri
develop
lrti
respiratori
symptom
onset
symptom
durat
fever
chest
radiograph
find
abnorm
breath
sound
statu
patient
age
sex
underli
diseas
transplant
method
interv
hsct
day
hospit
laboratori
find
retrospect
analyz
detail
fever
defin
measur
axillari
temperatur
higher
communityacquir
infect
defin
onset
symptom
within
hr
admiss
hospitalacquir
infect
defin
onset
symptom
greater
hr
admiss
clinic
diagnosi
classifi
uri
lrti
neutropenia
defin
absolut
neutrophil
count
lymphopenia
defin
absolut
lymphocyt
count
clinic
episod
defin
independ
clinic
episod
symptom
newli
develop
differ
respiratori
virus
detect
two
consecut
sampl
obtain
least
hr
apart
viru
detect
period
initi
symptom
sign
unresolv
specif
viru
regard
detect
singl
clinic
episod
codetect
defin
detect
respiratori
virus
differ
categor
variabl
test
chisquar
test
fisher
exact
test
data
analyz
use
spss
version
result
consid
statist
signific
p
valu
less
studi
approv
institut
review
board
seoul
nation
univers
hospit
need
inform
consent
waiv
clinic
characterist
patient
underw
hsct
consecut
studi
period
summar
tabl
one
hundredtwo
patient
male
patient
femal
median
age
yr
rang
yr
donor
type
autolog
patient
allogen
patient
differ
transplant
type
signific
virusposit
virusneg
group
vs
p
differ
underli
diseas
sex
signific
viru
detect
respiratori
virus
identifi
respiratori
sampl
nasopharyng
aspir
sputum
specimen
transtrach
aspir
bronchoalveolar
lavag
respect
sampl
obtain
patient
respiratori
viral
infect
document
separ
clinic
episod
except
sampl
persist
posit
viru
clinic
episod
respiratori
virus
identifi
episod
occur
children
rhinoviru
detect
frequent
episod
rsv
adenoviru
hcov
influenza
viru
b
influenza
viru
hmpv
tabl
among
clinic
episod
codetect
occur
episod
rhinoviru
common
codetect
episod
monthli
distribut
detect
respiratori
virus
shown
fig
rhinoviru
detect
year
around
rsv
preval
decemb
march
total
isol
preval
june
septemb
total
isol
clinic
episod
virus
document
cough
common
symptom
time
laboratori
diagnosi
respiratori
viral
infect
fever
found
episod
median
durat
fever
day
rang
day
sputum
rhinorrhea
less
common
hsct
patient
followedup
least
one
year
median
followup
period
yr
rang
yr
yr
overal
episod
occur
within
day
hsct
occur
day
follow
hsct
occur
interim
regard
nosocomi
acquisit
respiratori
infect
episod
communityacquir
episod
hospitalacquir
time
laboratori
diagnosi
respiratori
viral
infect
patient
neutropenia
lymphopenia
median
absolut
neutrophil
count
anc
rang
median
absolut
lymphocyt
count
alc
rang
proport
viru
clinic
diagnosi
summar
tabl
rhinoviru
p
hcov
p
seem
present
commonli
uri
lrti
result
show
clinic
signific
adenoviru
commonli
associ
lrti
uri
p
clinic
diagnos
uri
episod
lrti
episod
comparison
clinic
characterist
uri
lrti
shown
tabl
transplant
type
sexual
factor
laboratori
find
significantli
differ
uri
lrti
shown
tabl
episod
recov
without
pulmonari
complic
intervent
episod
develop
complic
prophylact
therapeut
antibiot
use
episod
oxygen
requir
episod
pleural
effus
detect
chest
radiograph
episod
mechan
ventil
intens
care
unit
use
episod
mean
durat
ventil
use
day
among
clinic
episod
develop
hsct
patient
patient
die
respiratori
failur
directli
relat
respiratori
viral
infect
one
patient
underw
bone
marrow
transplant
bmt
relaps
acut
lymphocyt
leukemia
die
acut
respiratori
distress
adenovir
infect
anoth
patient
underw
peripher
blood
stem
cell
transplant
pbsct
acut
myeloplast
leukemia
die
respiratori
failur
adenovir
infect
immunosuppress
agent
discontinu
respiratori
symptom
aggrav
patient
receiv
treatment
cidofovir
mgkg
weekli
administ
dose
deceas
third
patient
underw
pbsct
hospit
relaps
acut
myelodysplast
leukemia
patient
suffer
chronic
graftversushost
diseas
gvhd
treat
prednisolon
infect
occur
immunosuppress
treatment
gvhd
confirm
respiratori
distress
aggrav
eventu
lead
death
studi
illustr
respiratori
viral
infect
common
among
children
undergon
hsct
studi
respiratori
virus
identifi
respiratori
sampl
rhinoviru
common
viru
second
rsva
third
lower
respiratori
tract
infect
diagnos
hospitalacquir
infect
episod
mani
recent
studi
report
commun
respiratori
virus
particularli
rsv
piv
signific
caus
morbid
mortal
among
hsct
recipi
howev
studi
respiratori
viral
infect
previous
healthi
children
similar
area
reveal
differ
result
rsv
common
detect
viru
follow
adenoviru
rhinoviru
hmpv
rel
low
preval
rhinoviru
human
coronaviru
impli
differ
exist
healthi
popul
children
undergon
hsct
review
case
nonbacteri
pneumonia
among
hsct
recipi
report
communityacquir
respiratori
viral
infect
howev
preval
respiratori
viral
infect
hsct
increasingli
report
rang
studi
respiratori
virus
detect
hsct
patient
preval
respiratori
viral
infect
among
hsct
patient
depend
diagnost
method
use
use
real
time
rtpcr
method
recent
common
usag
excel
sensit
comparison
convent
method
viral
cultur
immunofluoresc
stain
viral
antigen
report
frequenc
rsv
infect
vari
influenza
viru
infect
piv
infect
rhinoviru
infect
studi
demonstr
rhinoviru
frequent
detect
infect
howev
diagnost
technolog
use
studi
differ
therefor
result
studi
directli
compar
studi
prospect
studi
use
rtpcr
show
rhinoviru
common
isol
hsct
patient
similar
commun
epidemiolog
common
june
septemb
rsv
common
decemb
march
result
significantli
differ
studi
one
import
find
studi
great
proport
respiratori
viral
infect
acquir
hsct
patient
hospit
high
nosocomi
infect
rate
remind
us
import
contact
droplet
precaut
visitor
limit
case
specif
antivir
agent
difficult
use
clinic
prevent
use
method
reduc
respiratori
viral
infect
clinic
uri
common
predomin
present
respiratori
viral
infect
usual
resolv
without
therapi
studi
respiratori
viral
infect
limit
uri
progress
lrti
european
studi
total
respiratori
viral
infect
report
lrti
prospect
studi
adult
hsct
hematolog
malign
report
followup
period
patient
pneumonia
progress
pneumonia
lymphopenia
known
risk
factor
progress
lrti
studi
lymphopenia
signific
progress
lrti
studi
found
three
fatal
case
among
clinic
episod
develop
hsct
patient
fatal
case
basal
lung
condit
patient
poor
respiratori
distress
occur
howev
respiratori
viral
infect
trigger
respiratori
dysfunct
death
probabl
relat
respiratori
viral
infect
mani
studi
report
variou
mortal
fatal
rsv
relat
mortal
children
treat
acut
myeloid
leukemia
one
report
demonstr
pivassoci
fatal
among
hsct
recipi
studi
report
mortal
rate
respiratori
viral
infect
among
hsct
recipi
antivir
therapeut
option
respiratori
virus
except
influenza
viru
hsct
patient
neuramidas
inhibitor
oseltamivir
zanamivir
known
resolv
influenza
symptom
immunocompromis
patient
inhibitor
amantadin
rimantadin
use
center
limit
influenza
mani
side
effect
includ
antivir
resist
primari
therapi
rsv
best
studi
aerosol
ribavirin
howev
similar
viral
agent
use
problem
costeffect
research
report
aerosol
ribavirin
result
decreas
viral
load
differ
progress
pneumonia
aerosol
oral
ribavirin
use
therapi
piv
infect
transplant
recipi
conflict
result
variou
treatment
adenoviru
tri
includ
highdos
intraven
immunoglobulin
ribavirin
cidofovir
howev
clinic
efficaci
agent
remain
unclear
therapeut
limit
emphas
import
prevent
strategi
strict
infect
control
program
hospit
studi
includ
rel
larg
number
patient
enrol
one
center
howev
retrospect
studi
depend
medic
record
limit
clinic
evalu
particular
risk
factor
prognosi
respiratori
viral
infect
condit
regimen
presenc
graftversushost
diseas
take
histori
immunosuppress
agent
separ
principl
hospit
patient
investig
despit
limit
studi
meaning
consid
aspect
show
common
preval
respiratori
viral
infect
hsct
children
effort
aid
investig
clinic
featur
epidemiolog
charact
viru
infect
patient
popul
studi
demonstr
respiratori
viral
infect
rel
high
hsct
patient
half
respiratori
infect
acquir
hospit
find
emphas
import
prevent
strategi
respiratori
viral
infect
hsct
patient
high
risk
